No results for ‘’
Everest Organics Ltd
₹252
(0.40%)
Sat, 30 May 2026, 09:49 am
Distribution Services
Medical Distributors
24.5KEverest Organics Share Price Live Chart
1 Day
(0.40%)
No Result Found
Summary
Market Cap
260.53
Net Profit
-1.29
P/B
3.55
Sector P/E
45.42
P/E
0
EV/EBITDA
36.15
Debt/Equity (Industry)
0.17
Interest Cover (Industry)
18.17
ROCE (Industry)
20.59
RONW (Industry)
17.62
ROE
-2.23
ROCE
1.72
Debt/Equity
0.91
EPS (TTM)
6
Dividend Yield
0
Book Value
74.67
Interest Cover
0.38
Analysis
all
- Dividends paid are thoroughly covered by earnings (9.9x coverage).
- Everest Organics's pays a higher dividend yield than the bottom 25% of dividend payers in India (0.76%).
- Everest Organics is profitable, therefore cash runway is not a concern.
- Everest Organics is profitable, therefore cash runway is not a concern.
- Debt is well covered by operating cash flow (49.5%, greater than 20% of total debt).
- Everest Organics only just started paying a dividend, it is too early to tell if payments are increasing.
- It is too early to tell whether Everest Organics has stable dividend payments.
- Everest Organics's dividend is below the markets top 25% of dividend payers in India (3.08%).
- Everest Organics's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
- Everest Organics's level of debt (74%) compared to net worth is high (greater than 40%).
Shareholding
| Shareholders | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 |
|---|---|---|---|---|---|
| Promoters | 59.58 | 59.61 | 59.64 | 60.99 | 61.09 |
| FII | 0 | 0 | 0 | 0 | 0 |
| DII | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| Public | 40.40 | 40.37 | 40.33 | 38.98 | 38.89 |
| Government | 0 | 0 | 0 | 0 | 0 |
Technical Analysis
Support and Resistance
| Type | R3 | R2 | R1 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 412.50 | 334 | 302 | 255.50 | 223.50 | 177 | 98.50 |
| Fibonacci | 334 | 304.01 | 285.49 | 255.50 | 225.51 | 206.99 | 177 |
| Camarilla | 291.59 | 284.39 | 277.20 | 255.50 | 262.80 | 255.61 | 248.41 |
Pivots Level: Classic
R3
+157
412.50
R2
+78.50
334
R1
+46.50
302
S1
-32
223.50
S2
-78.50
177
S3
-157
98.50
Moving Average
Period
Value
10-EMA
261.35
20-EMA
260.70
30-EMA
262.97
50-EMA
274.95
100-EMA
308.71
200-EMA
332.30
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 29 May 2026 | board-meetings | Accounts, Quarterly Results | |
| 11 Feb 2026 | board-meetings | Quarterly Results | |
| 05 Aug 2025 | agm | ||
| 16 Dec 2024 | egm | ||
| 16 Sept 2024 | agm | ||
| 17 Aug 2023 | agm | ||
| 11 Aug 2022 | agm | ||
| 27 May 2022 | dividend | ₹0.50 Dividend /Share | 17 Sept 2022 |
| 05 Aug 2021 | agm | ||
| 12 Jun 2021 | dividend | ₹1.00 Dividend /Share | 11 Sept 2021 |
Peer Comparison
Everest Organics Ltd
Torrent Pharmaceuticals Ltd
Sun Pharmaceutical Industries Ltd
Divis Laboratories Ltd
Dr Reddys Laboratories Ltd
Cipla Ltd
Everest Organics Ltd About
Everest Organics is principally engaged in manufacturing of active pharmaceutical ingredients and Bulk drugs.
Industry
Pharmaceuticals - Indian - Bulk Drugs
Founded
1993
Headquarters
CEO
SUNDARA PRASAD VENKATA SATYA SRIKAKOLAPU
Employees
Contact
Website
http://www.everestorganicsltd.com
eolcs0405@gmail.com
Phone
91-8455-250113
Location
Aroor Village, Sadasivpet Mandal, Medak, Telangana, 502291
Everest Organics Ltd Company History
| Year | History |
|---|---|
| 1993 |
|
| 1995 |
|
| 2020 |
|